A Phase 1B/2 Study Of Navtemadlin Combined With Acalabrutinib In Btk Inhibitor Naive Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (Cll) Or Small Lymphocytic Lymphoma (Sll)
Acalabrutinib;Navtemadlin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1B/2 Study Of Navtemadlin Combined With Acalabrutinib In Btk Inhibitor Naive Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (Cll) Or Small Lymphocytic Lymphoma (Sll) ### Output: Acalabrutinib;Navtemadlin